Head and Neck Neoplasms
📧 Sign up to get email alerts when something new happens for Head and Neck Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Docetaxel Kabi (docetaxel) — Fresenius Kabi Deutschland GmbH
EU authorization of Docetaxel Kabi (docetaxel) for multiple cancer indications including head and neck neoplasms, non-small cell lung carcin…
-
EMA approval · 2026-07-15EMA Authorised: Erbitux (cetuximab) — Merck Europe B.V.
Erbitux (cetuximab) has been authorised by EMA for therapeutic areas including head and neck neoplasms and colorectal neoplasms.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Molecular and Genomic Profiling of Head and Neck Tumors
A clinical trial is recruiting to perform molecular and genomic profiling of head and neck tumors to characterize their genomic features.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors [Phase 2]
Phase 2 trial evaluating a spirulina-derived product for reducing radiation-induced oral mucositis in patients undergoing radiotherapy for h…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer [Phase 1]
A Phase 1 study evaluating Xevinapant in combination with radiation and chemotherapy for head and neck cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
This clinical trial investigates factors that sustain tobacco abstinence in cancer patients treated with radiotherapy or radiochemotherapy.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: 3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project [NA]
Completed clinical trial investigating 3D modeling of the cervico-facial region and cranial nerve tractography under the IMAG 2 ORL project.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma [NA]
A clinical trial update on quality of life comparing primary transoral robotic surgery (TORS) to IMRT for early-stage oropharyngeal squamous…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients [NA]
A completed clinical trial compared laser therapy to ozone therapy for oral mucositis in cancer patients. The brief indicates the study is f…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
The National Institute on Deafness and Other Communication Disorders (NIDCD) is recruiting for a clinical protocol to establish a biospecime…
-
CLINICAL_TRIALS withdrawal · 2025-10-28Clinical Trial Update: Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery [NA]
The clinical trial evaluating an online peri-operative education program for patients undergoing major head and neck surgery has been withdr…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery [Phase 1, Phase 2]
Bevonescein was studied in a Phase 1/2 trial to highlight nerves during head and neck surgery, including procedures for parotid and thyroid …
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients [Phase 1]
Phase 1 trial results for EPO906 in combination with radiation therapy in cancer patients, including central nervous system neoplasms and he…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer [Phase 2, Phase 3]
A Phase 2/3 trial evaluating resistance exercise training for the shoulder and neck after head and neck cancer surgery has completed. The up…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating enoblituzumab in combination with retifanlimab or tebotolimab in head and neck cancer was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating durvalumab with cetuximab in previously treated recurrent or metastatic head and neck squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating monalizumab in combination with cetuximab for recurrent or metastatic squamous cell carcinoma of the h…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Image-guided Cryoablation of Head, Neck and Spine Tumors [NA]
Clinical trial on image-guided cryoablation for head, neck, and spine tumors has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2022-07-13Clinical Trial Update: Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery [Phase 2, Phase 3]
Clinical trial for levothyroxine in subclinical hypothyroidism after head and neck surgery was withdrawn.
-
EMA withdrawal · 2022-05-20EMA Withdrawn: Docetaxel Zentiva (previously Docetaxel Winthrop) (docetaxel) — Zentiva k.s.
The EMA has withdrawn Docetaxel Zentiva (docetaxel) from the market. The therapeutic areas formerly associated include head and neck neoplas…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. [Phase 2]
A Phase 2 pilot study evaluating the effects of an herbal gargle on oral mucositis induced by chemoradiotherapy in head and neck cancer pati…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] [Phase 2]
Phase 2 translational biomarker-driven umbrella study in head and neck squamous cell carcinoma and head and neck neoplasms completed.
-
EMA withdrawal · 2021-12-14EMA Withdrawn: Docetaxel Teva (docetaxel) — Teva B.V.
The EMA has withdrawn Docetaxel Teva, an injectable chemotherapy containing docetaxel, from the European market.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Study of AK-01 (LY3295668) in Solid Tumors [Phase 1, Phase 2]
A two-phase clinical trial evaluating AK-01 (LY3295668) in solid tumors has completed phases 1 and 2 with posted results.